Trends seem to suggest a possibility that newborn screening could reach more babies in the world. With new technologies and markets emerging in newborn screening, and regulatory bodies encouraging development of treatments for rare diseases, patients across the globe can benefit from current trends. But by unlocking new technologies and treatments, we face the challenge of ensuring that patients afflicted with rare diseases can be identified to receive those treatments. Traditional newborn screening can be expanded to include genetic sequencing to create a diagnostic force multiplier, helping to ensure patients have access to experimental and approved medicines. Public health systems conducting newborn screening have made great strides in the US, but cannot keep pace to screen for many more conditions that can be treated. Many other countries screen for only a few conditions, if any. This session is a discussion on possible solutions to ensure all babies can live their healthiest lives.

Ability Level: All

Session ID: 19831